Trial Profile
An Extended-Release Form of Clonidine as an Anti-Manic Agent: An Add-On, Open-Label Study
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 28 Apr 2017
Price :
$35
*
At a glance
- Drugs Clonidine (Primary)
- Indications Bipolar I disorders; Mania
- Focus Therapeutic Use
- 02 Mar 2017 New trial record